Dale B. Evans - Concepedia

Author

Dale B. Evans

Sterling Research Group (United States)

Also Known As

D B Evans, D. B. EVANS, D. B. Evans, D.B. Evans, Dale B. Evans, Dale Evans, Evans, Dale

Publications

1.5K

Citations

H-Index

Concepts

All Affiliations

Sterling Research Group (United States)Institute for Medical Research Bristol-Myers Squibb (Sweden)Warner University

About

Dale B. Evans is an author at Sterling Research Group (United States) specializing in pharmacology, medicine, and physiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	17	18	1K
2	Biochemistry	10	10	735
3	Natural Sciences	4	4	181
4	Health Sciences	3	3	118
5	Applied Physiology	1	1	58

Dale B. Evans

Publications

1.3K

Citations

H-Index

Page 1

	Year	Citations
Multiple molecular forms of cyclic nucleotide phosphodiesterase in cardiac and smooth muscle and in platelets Ronald E. Weishaar, Stephen D. Burrows, Dianne C. Kobylarz, Biochemical Pharmacology Cardiac MuscleMultiple Molecular FormsCyclic Nucleotide PhosphodiesteraseMolecular PhysiologyBiochemistry	1986	250
Cardiotonic agents. 1. 4,5-Dihydro-6-[4-(1H-imidazol-1-yl)phenyl]-3(2H)-pyridazinones: novel positive inotropic agents for the treatment of congestive heart failure James A. Bristol, Ila Sircar, Walter H. Moos, Journal of Medicinal Chemistry Heart FailureCardiovascular PharmacologyAltmetric Attention ScorePharmacotherapyPharmaceutical Chemistry	1984	150
Adenosine receptors mediating cardiac depression Dale B. Evans, J. A. Schenden, James A. Bristol Life Sciences Cardiac MuscleCardiomyopathyHeart FailureMolecular PhysiologyAdenosine Receptors	1982	111
Differential pharmacologic sensitivity of cyclic nucleotide phosphodiesterase isozymes isolated from cardiac muscle, arterial and airway smooth muscle Paul J. Silver, L T Hamel, Mark H. Perrone, European Journal of Pharmacology Molecular PharmacologyCardiac MuscleBiochemistryMedicinePhysiology	1988	109
Pharmacology of nadolol (SQ 11725), a β-adrenergic antagonist lacking direct myocardial depression Robert J. Lee, Dale B. Evans, Sherrin H. Baky, European Journal of Pharmacology Direct Myocardial DepressionMolecular PharmacologyMedicinePhysiologyCardiovascular Pharmacology	1975	96
Cardiotonic agents. 2. Synthesis and structure-activity relationships of 4,5-dihydro-6-[4-(H-imidazol-1-yl)phenyl]-3(2H)-pyridazinones: a new class of positive inotropic agents Ila Sircar, Bradley L. Duell, George Bobowski, Journal of Medicinal Chemistry Bioorganic ChemistryCardiovascular PharmacologyOrganic ChemistryPharmacotherapyHeterocycle Chemistry	1985	94
Phosphodiesterase Isozyme Inhibition, Activation of the cAMP System, and Positive Inotropy Mediated by Milrinone in Isolated Guinea Pig Cardiac Muscle Paul J. Silver, Alex L. Harris, Paul C. Canniff, Journal of Cardiovascular Pharmacology Cardiac MuscleMuscle FunctionPositive Inotropy MediatedCamp FormationCellular Physiology	1989	58
Phosphodiesterase Isozyme Inhibition, Activation of the cAMP System, and Positive Inotropy Mediated by Milrinone in Isolated Guinea Pig Cardiac Muscle Paul J. Silver, Alex L. Harris, Paul C. Canniff, Journal of Cardiovascular Pharmacology Camp SystemCardiac MuscleCardiomyopathyPhysiological ResearchMolecular Physiology	1989	55
Differential Vasorelaxant Effects of Milrinone and Amrinone on Contractile Responses of Canine Coronary, Cerebral, and Renal Arteries Alex L. Harris, Alison M. Grant, Paul J. Silver, Journal of Cardiovascular Pharmacology Calcium EntryHypertensionVascular DiseaseDifferential Vasorelaxant EffectsPharmacotherapy	1989	46
Modulation of cAMP Dale B. Evans Journal of Cardiovascular Pharmacology MechanobiologyCardiac MuscleSignal TransductionMolecular PhysiologyMedicine	1986	44

Page 1